Lipella Pharmaceuticals Inc. (LIPO) Operating income 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) annual operating income history from SEC filings — each fiscal year as reported.
-$5.1MFY2024 · since FY2021: -$1.9M → -$5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$5.1M | -7.0% |
| FY2023 | -$4.7M | -83.3% |
| FY2022 | -$2.6M | -35.2% |
| FY2021 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LIPO financial trends
LIPO RevenueLIPO Net incomeLIPO Net marginLIPO Gross profitLIPO Gross marginLIPO Operating marginLIPO Operating cash flowLIPO Free cash flowLIPO Capital expendituresLIPO Return on equityLIPO Stock buybacksLIPO Dividends paidLIPO Total assetsLIPO Total liabilitiesLIPO Shareholders’ equityLIPO overview →